✦ LIBER ✦

Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland

✍ Scribed by GEIR TRYGGVASON; BYLGJA HILMARSDOTTIR; GUðMUNDUR H. GUNNARSSON; JÓN JÓHANNES JÓNSSON; JÓN G. JÓNASSON; MAGNÚS K. MAGNÚSSON

Book ID: 109344079
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 185 KB
Volume: 118
Category: Article
ISSN: 0365-5555
DOI: 10.1111/j.1600-0463.2010.02643.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of gastrointestinal stromal t

Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors

✍ Suzanne George; Jayesh Desai 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 274 KB

Sunitinib, a multitargeted tyrosine kina

Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor

✍ Suzanne George 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 243 KB

Molecular analysis of secondary kinase m

Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors

✍ Ken-Hong Lim; Ming-Jer Huang; Li-Tzong Chen; Tsang-En Wang; Chien-Liang Liu; Che 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 194 KB

Mutations in gastrointestinal stromal tu

Mutations in gastrointestinal stromal tumors – a population-based study from Northern Norway

✍ SONJA E. STEIGEN; TOR J. EIDE; BARTOSZ WASAG; JERZY LASOTA; MARKKU MIETTINEN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Molecular basis for primary and secondar

Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor

✍ Mrinal M. Gounder; Robert G. Maki 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 744 KB

Gastrointestinal stromal tumors in Icela

Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study

✍ Geir Tryggvason; Hjörtur G. Gíslason; Magnús K. Magnússon; Jón G. Jónasson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

## Abstract Gastrointestinal stromal tumor (GIST) is a newly defined clinical and pathologic entity. This study examines the whole population‐based incidence of GIST as well as pathologic risk stratification schemes. All patients diagnosed in Iceland with a gastrointestinal mesenchymal tumor over t